Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings
P Rogliani, BL Ritondo, M Gabriele… - Expert Review of …, 2020 - Taylor & Francis
Introduction To date, there is solid evidence from randomized controlled trials (RCTs)
supporting the rationale for withdrawal from inhaled corticosteroids (ICSs) in most patients …
supporting the rationale for withdrawal from inhaled corticosteroids (ICSs) in most patients …
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
International guidance on chronic obstructive pulmonary disease (COPD) management
recommends the use of inhaled corticosteroids (ICS) in those patients at increased …
recommends the use of inhaled corticosteroids (ICS) in those patients at increased …
Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice
AG Kaplan - … Journal of Chronic Obstructive Pulmonary Disease, 2015 - Taylor & Francis
Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …
Withdrawal of inhaled corticosteroids in COPD: a meta-analysis
Background Conflicting findings exist on the benefit of withdrawal of inhaled corticosteroid
(ICS) in chronic obstructive pulmonary disease (COPD). We performed a quantitative …
(ICS) in chronic obstructive pulmonary disease (COPD). We performed a quantitative …
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
JD Chalmers, IF Laska, FME Franssen… - European …, 2020 - Eur Respiratory Soc
Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …
Inhaled corticosteroids for chronic obstructive pulmonary disease
M Cazzola, P Rogliani, L Novelli… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Current guidelines recommend the use of inhaled long-acting bronchodilators,
inhaled corticosteroids (ICSs) and their combinations for maintenance treatment of moderate …
inhaled corticosteroids (ICSs) and their combinations for maintenance treatment of moderate …
Weaning from inhaled corticosteroids in COPD: the evidence
The use of inhaled corticosteroids (ICS) in the treatment of chronic obstructive pulmonary
disease (COPD) has been widely debated [1–3]. Treatment guidelines have suggested that …
disease (COPD) has been widely debated [1–3]. Treatment guidelines have suggested that …
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: a proposal for COPD management
While chronic obstructive pulmonary disease (COPD) continues to be a major cause of
morbidity and mortality, pharmacological therapy has a definite benefit on symptoms as well …
morbidity and mortality, pharmacological therapy has a definite benefit on symptoms as well …
[HTML][HTML] Systematic review of inhaled corticosteroid withdrawal effects in chronic obstructive pulmonary disease, and comparison with two “real-life” studies
W Ye, X Guo, T Yang, F Han - Journal of Thoracic Disease, 2018 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is common and preventable. The long-term
safety of inhaled corticosteroid (ICS) use in COPD is still unclear and requires further …
safety of inhaled corticosteroid (ICS) use in COPD is still unclear and requires further …
Withdrawal of Inhaled Corticosteroids from Patients with COPD; Effect on Exacerbation Frequency and Lung Function: A Systematic Review
A Georgiou, R Ramesh, P Schofield… - … Journal of Chronic …, 2024 - Taylor & Francis
Background Inhaled corticosteroid (ICS) therapy has been demonstrated to reduce the risk
of COPD exacerbations. It should only be prescribed to COPD patients who are not …
of COPD exacerbations. It should only be prescribed to COPD patients who are not …